The success of copyright’s blockbuster initially drove a period of growth for pharma, but recent shifts present a murky outlook for investors. Off-patent competitors are eating into revenue, and persistent legal https://mathexqdv821672.digitollblog.com/41113363/sildenafil-and-the-pharmaceutical-industry-a-precarious-play